Literature DB >> 4209832

EM49, a new peptide antibiotic. 3. biological characterization in vitro and in vivo.

E Meyers, F E Pansy, H I Basch, R J McRipley, D S Slusarchyk, S F Graham, W H Trejo.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4209832     DOI： 10.7164/antibiotics.26.457

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  9 in total

Review 1.  Structure--activity relationships of polymyxin antibiotics.

Authors:  Tony Velkov; Philip E Thompson; Roger L Nation; Jian Li
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

Review 2.  Rediscovering the octapeptins.

Authors:  Tony Velkov; Kade D Roberts; Jian Li
Journal:  Nat Prod Rep       Date:  2017-03-17       Impact factor: 13.423

3.  Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.

Authors:  Chao-Dong Qian; Xue-Chang Wu; Yi Teng; Wen-Peng Zhao; Ou Li; Sheng-Guo Fang; Zhao-Hui Huang; Hai-Chun Gao
Journal:  Antimicrob Agents Chemother       Date:  2011-12-19       Impact factor: 5.191

4.  Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.

Authors:  Miranda E Pitt; Minh Duc Cao; Mark S Butler; Soumya Ramu; Devika Ganesamoorthy; Mark A T Blaskovich; Lachlan J M Coin; Matthew A Cooper
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

5.  Potentiation of the toxicity of mithramycin by bacterial lipopolysaccharide.

Authors:  S G Bradley; A C Adams; M C Smith
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

6.  Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria.

Authors:  Bernd Becker; Mark S Butler; Karl A Hansford; Alejandra Gallardo-Godoy; Alysha G Elliott; Johnny X Huang; David J Edwards; Mark A T Blaskovich; Matthew A Cooper
Journal:  Bioorg Med Chem Lett       Date:  2017-04-12       Impact factor: 2.823

7.  Simulations of octapeptin-outer membrane interactions reveal conformational flexibility is linked to antimicrobial potency.

Authors:  Xukai Jiang; Kai Yang; Bing Yuan; Bin Gong; Lin Wan; Nitin A Patil; James D Swarbrick; Kade D Roberts; Falk Schreiber; Lushan Wang; Tony Velkov; Jian Li
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

8.  Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.

Authors:  Elena K Schneider-Futschik; Olivia K A Paulin; Daniel Hoyer; Kade D Roberts; James Ziogas; Mark A Baker; John Karas; Jian Li; Tony Velkov
Journal:  ACS Infect Dis       Date:  2018-04-02       Impact factor: 5.084

9.  Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.

Authors:  Jessica L Chitty; Mark S Butler; Azzah Suboh; David J Edwards; Matthew A Cooper; James A Fraser; Avril A B Robertson
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.